<DOC>
	<DOCNO>NCT01411241</DOCNO>
	<brief_summary>The aim study ass whether second CYD dengue vaccination could administer concomitantly booster vaccination pediatric combination vaccine ( Pentaxim™ ) day visit 2 different site administration . Primary Objective : - To demonstrate non-inferiority antibody response antigen ( diphtheria , tetanus , pertussis , polio Hib ) participant receive one booster dose Pentaxim™ vaccine administer concomitantly second dose CYD dengue vaccine compare subject receive one booster dose Pentaxim™ vaccine administer concomitantly placebo . Secondary Objectives : - To describe safety Pentaxim™ vaccine administer concomitantly second dose CYD dengue vaccine , administer concomitantly placebo . - To describe safety CYD dengue vaccine subject dose . - To describe antibody response dengue virus serotype ( post-Dose 2 post-Dose 3 ) second dose CYD dengue vaccine administer concomitantly Pentaxim vaccine administer alone . - To describe antibody response dengue virus serotype post-Dose 2 post-Dose 3 subject .</brief_summary>
	<brief_title>Study Booster Injection Pentaxim™ Vaccine Administered With Dengue Vaccine Healthy Toddlers</brief_title>
	<detailed_description>Participants require 8 9 clinic visit receive total 7 injection . The dengue post-vaccinal viremia assess Visit 2 subset toddler . The dengue immunogenicity assess 28 day CYD dengue dose 2 dose 3 subset toddler . All participant followed-up safety vaccine dose 6 month last dengue vaccination .</detailed_description>
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Hemorrhagic Fevers , Viral</mesh_term>
	<mesh_term>Severe Dengue</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Aged 9 12 month day inclusion . Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg . Subject good health , base medical history physical examination . Documentation completion primary vaccination series Pentaxim vaccine 246 month regimen ± 2 week vaccination . Informed consent form sign dated parent legally acceptable representative ( 2 mandatory witness require local regulation ) . Subject parent/guardian able attend schedule visit comply trial procedure . Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede first trial vaccination . Planned participation another clinical trial present trial period . Planned receipt vaccine 4 week follow trial vaccination . Previous vaccination flavivirus disease , measles , mumps , rubella , previous booster vaccination pneumococcal disease , diphtheria , tetanus , pertussis , Haemophilus influenzae b ( Hib ) and/or polio . Receipt blood bloodderived product past 3 month might interfere assessment immune response . Known suspected congenital acquire immunodeficiency ; receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) . Personal seropositivity human immunodeficiency virus ( HIV ) hepatitis C report parent ( ) /legally acceptable representative . History pertussis and/or Hib infection report parent ( ) /legally acceptable representative . Known systemic hypersensitivity vaccine component , history lifethreatening reaction vaccine use trial vaccine contain substance . History contraindication receipt vaccine contain component Pentaxim vaccine ( diphtheria toxoid , tetanus toxoid , pertussis toxoid , filamentous hemagglutinin , polyribosylribitol phosphate [ PRP ] polio ) Trimovax ( measles , mumps rubella ) vaccine Prevenar ( pneumococcal ) vaccine . Thrombocytopenia , report parent ( ) /legally acceptable representative . Bleeding disorder , receipt anticoagulant 3 week precede inclusion , contraindicate intramuscular vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Dengue</keyword>
	<keyword>Dengue Hemorrhagic Fever</keyword>
	<keyword>CYD Dengue Vaccines</keyword>
	<keyword>Pentaxim™</keyword>
</DOC>